Related Experiment Video
Updated: Oct 13, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
Exploiting complex medical data with interpretable deep learning for adverse drug event prediction
Jonathan Rebane1, Isak Samsten1, Panagiotis Papapetrou1
1Department of Computer and Systems Sciences, Stockholm University, Stockholm, Sweden.
Abstract:
A variety of deep learning architectures have been developed for the goal of predictive modelling and knowledge extraction from medical records. Several models have placed strong emphasis on temporal attention mechanisms and decay factors as a means to include highly temporally relevant information regarding the recency of medical event occurrence while facilitating medical code-level interpretability. In this study we utilise such models with a large Electronic Patient Record (EPR) data set consisting of diagnoses, medication, and clinical text data for the purpose of adverse drug event (ADE) prediction. The first contribution of this work is an empirical evaluation of two state-of-the-art medical-code based models in terms of objective performance metrics for ADE prediction on diagnosis and medication data. Secondly, as an extension of previous work, we augment an interpretable deep learning architecture to permit numerical risk and clinical text features and demonstrate how this approach yields improved predictive performance compared to the other baselines. Finally, we assess the importance of attention mechanisms in regards to their usefulness for medical code-level and text-level interpretability, which may facilitate novel insights pertaining to the nature of ADE occurrence within the health care domain.
More Related Videos
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Overview and Classification